First Time Loading...

Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 41.72 USD 1.02%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

1.6B
+4%
Assets
Growth Rates:
1 Year
+103%
3 Years
+144%
5 Years
+189%
7 Years
+261%
10 Years
+356%
902m
+3%
Liabilities
Growth Rates:
1 Year
+301%
3 Years
+276%
5 Years
+330%
7 Years
+719%
10 Years
+864%
672.4m
+5%
Equity
Growth Rates:
1 Year
+23%
3 Years
+66%
5 Years
+101%
7 Years
+106%
10 Years
+167%

Balance Sheet Decomposition
Amphastar Pharmaceuticals Inc

1.6B
Assets
902m
Liabilities
1.6B
Assets
902m
Liabilities
Current Assets 555.1m
Cash & Short-Term Investments 289.6m
Receivables 138.9m
Other Current Assets 126.6m
Non-Current Assets 1B
Long-Term Investments 15.2m
PP&E 320.4m
Intangibles 607.1m
Other Non-Current Assets 76.6m
Current Liabilities 255.2m
Accounts Payable 36.5m
Accrued Liabilities 212.4m
Other Current Liabilities 6.3m
Non-Current Liabilities 646.8m
Long-Term Debt 594m
Other Non-Current Liabilities 52.8m

Balance Sheet
Amphastar Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
68
66
72
66
86
74
93
126
156
144
Cash Equivalents
68
66
72
66
86
74
93
126
156
144
Short-Term Investments
0
0
1
3
3
12
13
10
20
113
Total Receivables
23
34
27
42
52
46
66
79
89
115
Accounts Receivables
23
33
27
36
52
45
66
79
89
115
Other Receivables
0
0
0
6
0
0
0
0
0
1
Inventory
82
71
80
64
69
111
97
93
104
106
Other Current Assets
25
6
5
14
10
14
11
10
10
11
Total Current Assets
198
176
184
188
220
255
280
318
378
490
PP&E Net
138
142
153
181
210
254
281
272
265
316
PP&E Gross
138
142
153
181
210
254
281
272
265
316
Accumulated Depreciation
103
112
122
138
149
164
184
200
220
245
Intangible Assets
38
36
46
41
38
38
37
36
34
610
Goodwill
5
4
4
5
4
4
4
3
3
3
Long-Term Investments
0
0
0
0
0
0
0
4
2
15
Other Long-Term Assets
11
32
40
38
41
37
30
39
59
79
Other Assets
5
4
4
5
4
4
4
3
3
3
Total Assets
389
N/A
390
+0%
428
+10%
451
+5%
514
+14%
587
+14%
631
+8%
672
+6%
742
+10%
1 513
+104%
Liabilities
Accounts Payable
10
14
16
17
31
25
24
22
21
25
Accrued Liabilities
27
31
31
41
56
55
75
70
67
198
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
8
11
5
6
18
8
12
2
3
0
Other Current Liabilities
18
4
8
3
1
2
1
9
5
2
Total Current Liabilities
63
60
61
67
107
90
112
104
95
225
Long-Term Debt
36
30
32
41
32
39
34
75
73
590
Deferred Income Tax
6
0
2
1
1
1
1
1
0
0
Minority Interest
0
0
0
0
32
46
46
0
0
0
Other Liabilities
3
5
4
8
9
29
35
47
46
59
Total Liabilities
108
N/A
95
-12%
99
+4%
117
+19%
181
+54%
206
+14%
229
+11%
226
-1%
213
-6%
873
+310%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
63
60
71
73
68
116
118
180
272
409
Additional Paid In Capital
221
248
283
314
344
367
410
422
455
486
Treasury Stock
0
10
20
51
76
98
122
151
190
247
Other Equity
2
3
5
2
4
5
4
7
9
8
Total Equity
282
N/A
296
+5%
329
+11%
334
+1%
332
0%
381
+15%
402
+5%
446
+11%
529
+19%
639
+21%
Total Liabilities & Equity
389
N/A
390
+0%
428
+10%
451
+5%
514
+14%
587
+14%
631
+8%
672
+6%
742
+10%
1 513
+104%
Shares Outstanding
Common Shares Outstanding
45
45
46
47
47
47
48
48
48
48

See Also

Summary
AMPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMPH stock valuation using valuation multiples.
Wall Street Estimates
AMPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.